Medication Treatment for OUD in Residency Clinics

September 24, 2021

This training will help prepare the DFMCH clinics to offer medications for opioid use disorder by providing targeting training in the diagnosis and management of opioid use disorder and helping to design clinic-specific protocols to support this care. Faculty will complete MAT training prior to this event. The workshop will detail the logistical, legal and prescribing challenges common to MAT, and practical tips to overcome these barriers. We will also work with clinic staff (including RNs and possibly LCSWs and MAs) at this event to design clinic protocols with interprofessional input.

Target Audience

This program is designed for physicians who treat patients with opioid use disorder.

Learning Objectives

As a result of participating in this activity, learners will be able to: 

  1. Determine accurate diagnosis and initiate treatment for opioid use disorder
  2. Interpret urine toxicology screens as it relates to managing opioid use disorder
  3. Demonstrate skills needed to work with patients who continue to use drugs and alcohol while in treatment for opioid use disorder
  4. Determine appropriate treatment plan for OUD, including the initiation and maintenance of buprenorphine therapy
  5. Design clinic protocols for patient scheduling, rooming, triage calls, referrals to social work and behavioral health, and referral of complex patients for higher level of care
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit
    • 3.50 Wisconsin Responsible Opioid Prescribing Credit
  • 3.50 University of Wisconsin–Madison Continuing Education Hours
    • 3.50 Approved for AMA PRA Category 1 Credit™
    • 3.50 Wisconsin Responsible Opioid Prescribing Credit
Registration opens: 
09/20/2021
Course expires: 
11/05/2021
Event starts: 
09/24/2021 - 12:00pm
Event ends: 
09/24/2021 - 5:00pm
Cost:
$0.00
Rating: 
0

*All times listed are Central Daylight Time

Time

Session

12:00 pm - 12:15 pm

Welcome & Overview

12:15 pm - 1:00 pm

Opioid Use Disorder Diagnosis and Patient Evaluation

Dr. Alison Miller

1:00 pm - 1:15 pm 

Case Discussion / Q and A

1:15 pm - 2:00 pm 

Medication Initiation

Drs. Jillian Landeck and Randy Brown

2:00 pm - 2:15 pm 

Case Discussion / Q and A

2:15 pm - 2:30 pm

Break

2:30 pm - 3:30 pm 

Breakout Groups 

- Clinical Roles
- Logistics
- Protocols

3:30 pm - 3:45 pm 

Case Discussion: Common Challenges 

3:45 pm - 4:00 pm

Support Resources
4:00 pm Adjourn

 

All times CDT. A link to the session will be emailed prior to the event, and will also be available at this course site.

Policy on Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be commercial interests.

 

Discloser List CME Internal Report

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live online activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Wisconsin Medical Examining Board Opioid CME

This course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code.
Course title: Medication Treatment for OUD in Residency Clinics
Course Director: Jillian Landeck, MD, MA – Family Physician
Instructors: Anna Helwig, RN, Elizabeth M Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM; Randall T. Brown, MD, PhD, DFASAM

Number of Credits Approved: 3.5

Ref # MED-1110

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .35 CEUs or 3.5 hours.

 

Available Credit

  • 3.50 AMA PRA Category 1 Credit
    • 3.50 Wisconsin Responsible Opioid Prescribing Credit
  • 3.50 University of Wisconsin–Madison Continuing Education Hours
    • 3.50 Approved for AMA PRA Category 1 Credit™
    • 3.50 Wisconsin Responsible Opioid Prescribing Credit

Price

Cost:
$0.00
Please login or register to take this course.

All times listed are Central Daylight Time (CDT)

QUESTIONS ABOUT REGISTRATION

Email help@icep.wisc.edu.

PROGRAM CHANGES

Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.

ACCESSIBILITY

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu

FOR FURTHER INFORMATION

For additional questions about the conference, including accessibility requests, please contact:

Kathleen Maher
kathleen.maher@fammed.wisc.edu

Required Hardware/software